Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol versus remifentanil during postoperative extubation after radical resection of endometrial carcinoma
ChiCTR1900025773Phase 4Not yet recruiting
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Oct 2019
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of propofol and remifentanil in endometrial cancer (EC) (2 arms), sponsored by Jiangsu Provincial People's Hospital. Primary endpoints: Recovery time and Bispectral index. Planned start Oct 2019; status: not yet recruiting.
02
Drugs
propofolremifentanil
03
Conditions
endometrial cancer (EC)
Beyond the preview
Go deeper on ChiCTR1900025773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900025773.